Analyst Consensus ?
ConsensusBuy35 ratings
Bullish2365.7%
Neutral1131.4%
Bearish12.9%
Equifax Inc. · EFX · FY2026 Q2 · Calendar Q3 2026
Equifax Q2 Revenue Beats on AI-Driven Margins, but Stock Drops 5%
Equifax delivered a solid Q2 with revenue of $1.7 billion (up 11% YoY) and EPS of $2.25 (up 13%), narrowly beating consensus on both lines. The quarter showcased compounding AI-driven cost efficiency — EBITDA margin expanded 120 bps to nearly 35% — alongside proprietary data monetization through TWN Indicator and government contracts. Management raised constant-currency guidance and announced a $750 million acquisition of Círculo de Crédito to expand in Mexico. Despite operational strength, the stock sold off roughly 5% on the event day with volume 3.9x baseline, suggesting the market questioned whether mortgage rate sensitivity, the $40 million legal settlement charge, and AI productivity gains already priced into a stock near $176 against a $212 consensus target. A modest +1.8% subsequent drift pointed to partial recovery, but the reaction underscored skepticism about sustained…
Reported Before market openNYSEIndustrials
$20.69B market cap
100quality score
Company context
Snapshot as of publicationEquifax Inc. operates as a global data and analytics company, delivering a range of information solutions and specialized human resources administrative process outsourcing services. Its clientele spans across businesses, governmental organizations, and individual consumers. The company's operations are structured into three primary divisions: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment specializes in employment-related data, offering verification services for income, employment history, criminal records, and Social Security numbers. It also provides tools for payroll-based transactions, employment tax management, and products aimed at protecting against identity theft. The U.S. Information Solutions (USIS) segment provides a comprehensive suite of services for both consumers and businesses within the United States.…
Earnings scorecard
Reported versus consensus
Reported EPS
$2.25
Consensus $2
EPS surprise
+2.3%
Reported versus consensus
Reported revenue
$1.70B
Consensus $1.70B
Revenue surprise
+0.2%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$176.13Current
$182Low
$247.78Average
$331High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Needham | Buy | Buy | Maintain | Jul 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 2, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 19, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 9, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 12, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Dec 8, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 15, 2025 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Dec 16, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 12, 2024 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Feb 13, 2024 |
| Truist Securities | Buy | Buy | Maintain | Feb 9, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jan 11, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 15, 2022 |
| Argus Research | Buy | Hold | Upgrade | Oct 22, 2021 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jun 9, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 21, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 18, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Oct 2, 2019 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 26, 2019 |
| Argus | Hold | Hold | Maintain | Sep 15, 2017 |
| William Blair | Outperform | Outperform | Maintain | Apr 8, 2016 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 30, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 18, 2014 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Feb 19, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $176.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $208 | $169.84 | +18.1% | Jul 22, 2026 |
| Needham | Kyle Peterson | $245 | $173 | +39.1% | Jul 22, 2026 |
| Wells Fargo | Jason Haas | $212 | $173 | +20.4% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $225 | $173 | +27.7% | Jul 22, 2026 |
| Robert W. Baird | Analyst unavailable | $232 | $173 | +31.7% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $200 | $173 | +13.6% | Jul 22, 2026 |
| RBC Capital | Ashish Sabadra | $194 | $173 | +10.1% | Jul 22, 2026 |
| Goldman Sachs | George Tong | $182 | $173 | +3.3% | Jul 21, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $167.22 | +19.2% | Jul 2, 2026 |
| Goldman Sachs | George Tong | $173 | $151.93 | -1.8% | Jun 26, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $154.84 | +24.9% | Jun 18, 2026 |
| UBS | Analyst unavailable | $215 | $165.13 | +22.1% | Jun 16, 2026 |
| UBS | Kevin McVeigh | $220 | $176.38 | +24.9% | Apr 23, 2026 |
| Mizuho Securities | Analyst unavailable | $222 | $186.85 | +26.0% | Apr 16, 2026 |
| Goldman Sachs | Analyst unavailable | $208 | $193.55 | +18.1% | Feb 6, 2026 |
| RBC Capital | Ashish Sabadra | $222 | $188.19 | +26.0% | Feb 5, 2026 |
| Needham | Analyst unavailable | $265 | $184.57 | +50.5% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $184.63 | +33.4% | Feb 5, 2026 |
| RBC Capital | Analyst unavailable | $220 | $183.44 | +24.9% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $195 | $181.04 | +10.7% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $250 | $181.04 | +41.9% | Feb 5, 2026 |
| UBS | Analyst unavailable | $230 | $181.04 | +30.6% | Feb 5, 2026 |
| Barclays | Manav Patnaik | $215 | $181.04 | +22.1% | Feb 5, 2026 |
| Morgan Stanley | Toni Kaplan | $244 | $181.04 | +38.5% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $280 | $220.77 | +59.0% | Dec 17, 2025 |
| BMO Capital | Analyst unavailable | $234 | $211.51 | +32.9% | Dec 8, 2025 |
| BMO Capital | Analyst unavailable | $245 | $229.93 | +39.1% | Oct 22, 2025 |
| Stifel Nicolaus | Analyst unavailable | $253 | $231.31 | +43.6% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $285 | $228.33 | +61.8% | Oct 15, 2025 |
| Oppenheimer | Analyst unavailable | $271 | $230.81 | +53.9% | Oct 13, 2025 |
| UBS | Analyst unavailable | $297 | $256.25 | +68.6% | Sep 15, 2025 |
| UBS | Kevin McVeigh | $278 | $243.56 | +57.8% | Jul 23, 2025 |
| Bank of America Securities | Joshua Dennerlein | $285 | $255.08 | +61.8% | Jun 23, 2025 |
| RBC Capital | Ashish Sabadra | $300 | $243.45 | +70.3% | Mar 20, 2025 |
| BNP Paribas | Andrew Grobler | $305 | $260.55 | +73.2% | Dec 16, 2024 |
| Citigroup | Arthur Truslove | $331 | $285.2 | +87.9% | Oct 11, 2024 |
| BNP Paribas | Andrew Grobler | $310 | $297.57 | +76.0% | Sep 19, 2024 |
| Barclays | Manav Patnaik | $380 | $297.77 | +115.7% | Sep 13, 2024 |
| New Street | Toni Kaplan | $271 | $297.99 | +53.9% | Sep 12, 2024 |
| Needham | Kyle Peterson | $350 | $305.12 | +98.7% | Aug 28, 2024 |
| Wells Fargo | Jason Haas | $340 | $283.59 | +93.0% | Aug 12, 2024 |
| Needham | Kyle Peterson | $320 | $265.9 | +81.7% | Jul 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $305 | $264.19 | +73.2% | Jul 19, 2024 |
| Oppenheimer | Owen Lau | $300 | $260.3 | +70.3% | Jul 19, 2024 |
| Goldman Sachs | George Tong | $277 | $264.19 | +57.3% | Jul 18, 2024 |
| Evercore ISI | David Togut | $305 | $272.15 | +73.2% | Jul 18, 2024 |
| Oppenheimer | Owen Lau | $272 | $217.51 | +54.4% | Apr 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $265 | $217.51 | +50.5% | Apr 19, 2024 |
| Robert W. Baird | Jeffrey Meuler | $260 | $217.51 | +47.6% | Apr 19, 2024 |
| Morgan Stanley | Toni Kaplan | $240 | $217.51 | +36.3% | Apr 18, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $295 | $262.74 | +67.5% | Apr 9, 2024 |
| Evercore ISI | David Togut | $310 | $247.94 | +76.0% | Feb 13, 2024 |
| Deutsche Bank | Faiza Alwy | $267 | $230.38 | +51.6% | Dec 7, 2023 |
| RBC Capital | Ashish Sabadra | $205 | $202.29 | +16.4% | Apr 21, 2023 |
| Truist Financial | Analyst unavailable | $260 | $222.56 | +47.6% | Feb 6, 2023 |
| Wells Fargo | Analyst unavailable | $210 | $217.56 | +19.2% | Jan 13, 2023 |
| Morgan Stanley | Analyst unavailable | $197 | $205.76 | +11.8% | Jan 4, 2023 |
| Stifel Nicolaus | Stifel Stifel | $222 | $192.63 | +26.0% | Dec 16, 2022 |
| J.P. Morgan | Analyst unavailable | $219 | $201.85 | +24.3% | Nov 18, 2022 |
| Atlantic Equities | Simon Clinch | $230 | $207.1 | +30.6% | Nov 15, 2022 |
| Needham | Analyst unavailable | $230 | $193.99 | +30.6% | Nov 14, 2022 |
| Morgan Stanley | Analyst unavailable | $212 | $172.07 | +20.4% | Sep 27, 2022 |
| Barclays | Analyst unavailable | $230 | $193.99 | +30.6% | Jul 27, 2022 |
| Deutsche Bank | Analyst unavailable | $221 | $201.22 | +25.5% | Jul 22, 2022 |
| Truist Financial | Andrew Jeffrey | $230 | $200.56 | +30.6% | Jul 22, 2022 |
| Morgan Stanley | Analyst unavailable | $230 | $200.56 | +30.6% | Jul 22, 2022 |
| Credit Suisse | Analyst unavailable | $245 | $200.52 | +39.1% | Jul 21, 2022 |
| Stifel Nicolaus | Analyst unavailable | $223 | $183.14 | +26.6% | Jul 1, 2022 |
| Morgan Stanley | Toni Kaplan | $227 | $184.94 | +28.9% | Jun 28, 2022 |
| Evercore ISI | David Togut | $200 | $203.52 | +13.6% | Apr 29, 2022 |
| Barclays | Analyst unavailable | $250 | $206.53 | +41.9% | Apr 22, 2022 |
| Credit Suisse | Analyst unavailable | $250 | $206.44 | +41.9% | Apr 22, 2022 |
| Deutsche Bank | Analyst unavailable | $225 | $202.95 | +27.7% | Apr 22, 2022 |
| Goldman Sachs | George Tong | $221 | $202.95 | +25.5% | Apr 21, 2022 |
| RBC Capital | Analyst unavailable | $244 | $221.41 | +38.5% | Apr 21, 2022 |
| Morgan Stanley | Toni Kaplan | $250 | $202.95 | +41.9% | Apr 21, 2022 |
| Needham | Kyle Peterson | $275 | $202.95 | +56.1% | Apr 21, 2022 |
| Robert W. Baird | Jeffrey Meuler | $281 | $221.41 | +59.5% | Apr 20, 2022 |
| Deutsche Bank | Faiza Alwy | $265 | $214.14 | +50.5% | Apr 18, 2022 |
| Barclays | Manav Patnaik | $300 | $235.46 | +70.3% | Mar 27, 2022 |
| Cowen & Co. | Georgios Mihalos | $295 | $228.23 | +67.5% | Jan 20, 2022 |
| BNP Paribas | George Gregory | $290 | $280.26 | +64.7% | Nov 22, 2021 |
| Jefferies | Hamzah Mazari | $320 | $274.74 | +81.7% | Nov 11, 2021 |
| Argus Research | David Coleman | $285 | $267.42 | +61.8% | Oct 22, 2021 |
| Goldman Sachs | George Tong | $267 | $248.56 | +51.6% | Jul 22, 2021 |
| Credit Suisse | Kevin Mcveigh | $270 | $220.02 | +53.3% | Apr 22, 2021 |
Track every rating change on EFX the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
-3.9%
Event window
SPY move
+0.8%
Same window
Abnormal move
-4.8%
Stock minus SPY
Volume
3.9×
Versus trailing sessions
Subsequent drift
+1.8%
Up to 20 sessions
EFXSPY benchmark
Follow EFX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Versus Q1 2026: revenue growth decelerated from 14% to 11% YoY; EBITDA margin expansion accelerated from 80 bps to 120 bps (reaching nearly 35%); guidance sentiment upgraded from maintained to raised on a constant-currency basis; AI cost savings target doubled from $75M to $150M; a new $750M Círculo de Crédito acquisition was announced (no acquisitions in Q1); a $40M legal settlement charge was recorded; government contract wins totaled $300M ACV; 54 AI-embedded products launched with Vitality Index at 16%; and the mortgage narrative shifted from Q1's 38% surge to a more cautious outlook amid persistently higher rates.
Guidance delta
Management raised constant-currency full-year targets while reaffirming reported guidance. This marks an upgrade from Q1, when guidance was merely maintained citing Iran conflict and rate volatility uncertainty. Forward plans include completing the Círculo de Crédito acquisition in Q4 2026 (pending regulatory approvals), maintaining $1 VantageScore pricing through 2027, scaling AI deployment across operations, technology and G&A, and growing government business with state contracts targeting 2027 rollout.
Key takeaways
- Revenue of $1.7 billion beat estimates by a narrow margin, growing 11% YoY.
- EPS of $2.25 topped the $2.20 consensus by 2.3%.
- EBITDA margin expanded 120 bps to nearly 35%, driven by AI efficiency and operating leverage.
- AI cost savings target doubled from $75M to $150M within the year.
- $750M Círculo de Crédito acquisition announced to expand Mexican credit data footprint at a 9.4x EBITDA multiple.
- Government contract pipeline reached $300M ACV with 2027 rollout expected.
Management priorities
- Complete Círculo de Crédito acquisition in Q4 2026, pending regulatory approvals.
- Scale AI deployment across operations, technology, and G&A to achieve the $150M savings target.
- Expand AI-driven products including Ignite AI Advisor and Equifax IQ globally.
- Maintain $1 VantageScore pricing through 2027 to drive adoption among mortgage originators.
- Grow government business with state contracts targeting 2027 rollout.
Related earnings events
IndustrialsROL · FY2026 Q2 · Calendar Q3 2026Rollins Q2 2026: Revenue Misses as Digital Lead Slowdown Hits OrkinLUV · FY2026 Q2 · Calendar Q3 2026Southwest Airlines Q2 2026: EPS Beats by 84%, Unit Revenue Up 20%, Guidance Cut on FuelDOV · FY2026 Q2 · Calendar Q3 2026Dover Raises EPS Guidance but Shares Fall 8% on Revenue Miss and Refrigeration Issues
Sources
- Earnings call transcript and parsed analysis · 2026-07-21T18:03:33.883118+00:00
- FN2 earnings calendar · 2026-07-31T01:23:16.182055+00:00
- Polygon adjusted daily market bars · 2026-07-31T02:13:04.124743+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T02:13:04.122055+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.